Correlation Between Bone Biologics and Tandem Diabetes

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Tandem Diabetes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Tandem Diabetes into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and Tandem Diabetes Care, you can compare the effects of market volatilities on Bone Biologics and Tandem Diabetes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Tandem Diabetes. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Tandem Diabetes.

Diversification Opportunities for Bone Biologics and Tandem Diabetes

0.89

Correlation Coefficient

Bone Biologics  Tandem Diabetes

Very poor diversification

The 3 months correlation between Bone and Tandem is 0.89. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Tandem Diabetes Care in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tandem Diabetes Care and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Tandem Diabetes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tandem Diabetes Care has no effect on the direction of Bone Biologics i.e., Bone Biologics and Tandem Diabetes go up and down completely randomly.

Pair Corralation between Bone Biologics and Tandem Diabetes

Assuming the 90 days horizon Bone Biologics Corp is expected to generate 8.44 times more return on investment than Tandem Diabetes. However, Bone Biologics is 8.44 times more volatile than Tandem Diabetes Care. It trades about 0.07 of its potential returns per unit of risk. Tandem Diabetes Care is currently generating about -0.15 per unit of risk. If you would invest  6,050  in Bone Biologics Corp on September 4, 2024 and sell it today you would lose (3,270) from holding Bone Biologics Corp or give up 54.05% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	97.62%
Values	Daily Returns

Bone Biologics Corp  vs.  Tandem Diabetes Care

Bone Biologics Corp

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Bone Biologics Corp are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile technical and fundamental indicators, Bone Biologics showed solid returns over the last few months and may actually be approaching a breakup point.

Tandem Diabetes Care

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Tandem Diabetes Care has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's fundamental indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Bone Biologics and Tandem Diabetes

The main advantage of trading using opposite Bone Biologics and Tandem Diabetes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Tandem Diabetes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tandem Diabetes will offset losses from the drop in Tandem Diabetes' long position.

The idea behind Bone Biologics Corp and Tandem Diabetes Care pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.